Altus Medical announced today that it has been granted clearance by the U.S. Food and Drug Administration (FDA) to market the CoolGlide® aesthetic laser system for permanent hair reduction. This clearance, the first given to a product with CoolGlide’s unique wavelength, was supported with data from a long-term clinical study.
Suzanne Kilmer, M.D., Director of the Laser and Skin Surgery Center of Northern California and principal clinical investigator comments, "The clinical data collected over the course of the study demonstrates that the CoolGlide® is safe and effective for permanent hair reduction." She adds, "This is exciting news for practitioners interested in offering their patients permanent hair reduction provided by safe, state-of-the-art laser technology."
CoolGlide® provides a fast, safe and effective way to remove unwanted hair in the broadest range of skin types including tanned patients. In addition to removing unwanted hair, the system is now cleared for the treatment of a broad range of vascular lesions, including leg veins.